Viral Hepatitis is a group of infectious diseases that affect the liver and can lead to severe health complications if left untreated. It is caused by different viruses, including hepatitis A, B, C, D, and E. Each type varies in transmission routes and severity of symptoms. Hepatitis A is typically contracted through contaminated food or water, while hepatitis B and C spread through contact with infected blood or body fluids such as during unprotected sex or sharing needles. Hepatitis D occurs only in individuals already infected with hepatitis B, whereas hepatitis E is usually transmitted through consuming contaminated water or undercooked meat. Symptoms may range from mild fatigue to jaundice (yellowing of the skin and eyes), dark urine, abdominal pain, nausea/vomiting, and loss of appetite. Although some people might remain asymptomatic for years after infection with viral hepatitis types B and C known as chronic infections - it can eventually cause cirrhosis (scarring) of the liver leading to organ failure or hepatocellular carcinoma (liver cancer). Early diagnosis through blood tests allows for treatments aiming at suppressing virus replication successfully; however, vaccination remains the most effective prevention method against this global health concern
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation